These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12399735)

  • 1. [Age related macular degeneration: a review of anti-angiogenic treatments].
    Razavi S; Coscas G; Soubrane G
    J Fr Ophtalmol; 2002 Sep; 25(7):747-52. PubMed ID: 12399735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current treatment of choroidal neovascularization in age-related macular degeneration].
    Donati G
    J Fr Ophtalmol; 2002 Sep; 25(7):740-6. PubMed ID: 12399734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM
    Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
    Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
    Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Feeder vessel treatment of choroidal neovascularization in age-related macular degeneration].
    Coscas F; Stanescu D; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Jun; 26(6):602-8. PubMed ID: 12910200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of therapies in development for the treatment of age-related macular degeneration.
    Hunt DW; Margaron P
    IDrugs; 2003 May; 6(5):464-9. PubMed ID: 12789601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Vine AK; Brewer GJ
    Trans Am Ophthalmol Soc; 2002; 100():73-6; discussion 76-7. PubMed ID: 12545680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
    Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration.
    Shah AR; Del Priore LV
    Ophthalmology; 2009 Oct; 116(10):1901-7. PubMed ID: 19592101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
    Maguire MG; Alexander J; Fine SL;
    Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD].
    Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H; ; ;
    Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related macular degeneration.
    Brucker AJ
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
    Boyer DS; Antoszyk AN; Awh CC; Bhisitkul RB; Shapiro H; Acharya NR;
    Ophthalmology; 2007 Feb; 114(2):246-52. PubMed ID: 17270674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wet age-related macular degeneration.
    Kulkarni AD; Kuppermann BD
    Adv Drug Deliv Rev; 2005 Dec; 57(14):1994-2009. PubMed ID: 16309781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Krypton laser photocoagulation at low power setting for age-related macular degeneration complicated with subfoveal choroidal neovascularization].
    Zhang CF; Jia Y; Li ZQ; Du H; Han BL
    Zhonghua Yan Ke Za Zhi; 2004 Dec; 40(12):808-11. PubMed ID: 15733431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.
    Regillo CD; Brown DM; Abraham P; Yue H; Ianchulev T; Schneider S; Shams N
    Am J Ophthalmol; 2008 Feb; 145(2):239-248. PubMed ID: 18222192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical removal of peripapillary choroidal neovascularization associated with age-related macular degeneration.
    Blinder KJ; Shah GK; Thomas MA; Holekamp NM; Joseph DP; Grand MG; Sharma S
    Ophthalmic Surg Lasers Imaging; 2005; 36(5):358-64. PubMed ID: 16238033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments in age-related macular degeneration.
    Hooper CY; Guymer RH
    Clin Exp Ophthalmol; 2003 Oct; 31(5):376-91. PubMed ID: 14516424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of neovascularization.
    York J; Glaser B; Murphy R
    J Ophthalmic Nurs Technol; 2000; 19(4):194-7. PubMed ID: 11309996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related macular degeneration: beyond anti-angiogenesis.
    Kent DL
    Mol Vis; 2014 Jan; 20():46-55. PubMed ID: 24426775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.